These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 37121252

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. All-cause health care resource utilization and costs among adults with alopecia areata: A retrospective claims database study in the United States.
    Mostaghimi A, Gandhi K, Done N, Ray M, Gao W, Carley C, Wang T, Swallow E, Sikirica V.
    J Manag Care Spec Pharm; 2022 Apr; 28(4):426-434. PubMed ID: 35332790
    [Abstract] [Full Text] [Related]

  • 23. Direct health care costs associated with COVID-19 in the United States.
    DeMartino JK, Swallow E, Goldschmidt D, Yang K, Viola M, Radtke T, Kirson N.
    J Manag Care Spec Pharm; 2022 Sep; 28(9):936-947. PubMed ID: 35722829
    [Abstract] [Full Text] [Related]

  • 24. Health care utilization and costs associated with functional status in patients with psoriatic arthritis.
    Ogdie A, Hwang M, Veeranki P, Portelli A, Sison S, Shafrin J, Pedro S, Hass S, Hur P, Kim N, Yi E, Michaud K.
    J Manag Care Spec Pharm; 2022 Sep; 28(9):997-1007. PubMed ID: 36001101
    [Abstract] [Full Text] [Related]

  • 25. CME/CNE Article: A Framework of Care in Multiple Sclerosis, Part 1: Updated Disease Classification and Disease-Modifying Therapy Use in Specific Circumstances.
    Newsome SD, Aliotta PJ, Bainbridge J, Bennett SE, Cutter G, Fenton K, Lublin F, Northrop D, Rintell D, Walker BD, Weigel M, Zackowski K, Jones DE.
    Int J MS Care; 2016 Sep; 18(6):314-323. PubMed ID: 27999526
    [Abstract] [Full Text] [Related]

  • 26. [Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].
    Llorca PM, Miadi-Fargier H, Lançon C, Jasso Mosqueda G, Casadebaig F, Philippe A, Guillon P, Mehnert A, Omnès LF, Chicoye A, Durand-Zaleski I.
    Encephale; 2005 Sep; 31(2):235-46. PubMed ID: 15959450
    [Abstract] [Full Text] [Related]

  • 27. Health care costs and resource utilization among commercially insured adult patients with hemophilia A managed with FVIII prophylaxis in the United States.
    Thornburg CD, Adamski K, Cook K, Vembusubramanian M, Sendhil SR, Hinds D, Chen E, Sammon J, Solari P, Garrison LP, Croteau SE.
    J Manag Care Spec Pharm; 2022 Apr; 28(4):449-460. PubMed ID: 34958235
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Characteristics and Healthcare Burden of Patients with Schizophrenia Treated in a US Integrated Healthcare System.
    Mahabaleshwarkar R, Lin D, Joshi K, Fishman J, Blair T, Hetherington T, Palmer P, Patel C, Krull C, Tcheremissine OV.
    J Ment Health Policy Econ; 2021 Jun 01; 24(2):47-59. PubMed ID: 34151777
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Economic burden and antidepressant treatment patterns among patients with major depressive disorder in the United States.
    Zhu L, Ferries E, Suthoff E, Namjoshi M, Bera R.
    J Manag Care Spec Pharm; 2022 Nov 01; 28(11-a Suppl):S2-S13. PubMed ID: 36242598
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Health care resource utilization and costs among patients with multiple myeloma with exposure to double-class or triple-class multiple myeloma treatments: A retrospective US claims database analysis.
    Yang J, Boytsov N, Carlson JJ, Barthold D.
    J Manag Care Spec Pharm; 2023 Aug 01; 29(8):917-926. PubMed ID: 37523320
    [Abstract] [Full Text] [Related]

  • 37. Real-world persistence, adherence, health care resource utilization, and costs in people with type 2 diabetes switching from a first-generation basal insulin to a second-generation (insulin glargine 300 U/mL) vs an alternative first-generation basal insulin.
    Wright EE, Malone DC, Trujillo JM, Gill J, Huse S, Li X, Zhou FL, Preblick R, Reid T.
    J Manag Care Spec Pharm; 2022 Jun 01; 28(6):592-603. PubMed ID: 35352995
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Schizophrenia population health management: perspectives of and lessons learned from population health decision makers.
    Roach M, Lin D, Graf M, Pednekar P, Chou JW, Benson C, Doshi JA.
    J Manag Care Spec Pharm; 2021 Oct 01; 27(10-a Suppl):S2-S13. PubMed ID: 34652218
    [Abstract] [Full Text] [Related]

  • 40. LBA02-09 EMBARK: A Phase 3 Randomized Study of Enzalutamide or Placebo Plus Leuprolide Acetate and Enzalutamide Monotherapy in High-risk Biochemically Recurrent Prostate Cancer.
    J Urol; 2023 Jul 01; 210(1):224-226. PubMed ID: 37119051
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.